Supernus Pharmaceuticals shares owned by Group One Trading
Quarter-by-quarter ownership of Supernus Pharmaceuticals shares owned by Group One Trading
from 13F filings
Historical chart of Group One Trading investment in Supernus Pharmaceuticals
Tip: Access up to 7 years of quarterly data
All positions including Supernus Pharmaceuticals held by Group One Trading consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Supernus Pharmaceuticals by Group One Trading
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $53k | 1.7k | 31.18 |
| 2023-09-30 | $2.8k | 100 | 27.57 |
| 2022-06-30 | $9.0k | 300 | 30.00 |
| 2022-03-31 | $10k | 300 | 33.33 |
| 2021-12-31 | $9.0k | 300 | 30.00 |
| 2021-09-30 | $19k | 700 | 27.14 |
| 2021-06-30 | $209k | 6.8k | 30.74 |
| 2021-03-31 | $45k | 1.7k | 26.47 |
| 2020-12-31 | $58k | 2.3k | 25.22 |
| 2020-09-30 | $13k | 600 | 21.67 |
| 2020-06-30 | $1.1M | 44k | 23.76 |
| 2020-03-31 | $1.1M | 62k | 17.99 |
| 2019-12-31 | $695k | 29k | 23.72 |
| 2019-09-30 | $2.8M | 103k | 27.48 |
| 2019-06-30 | $827k | 25k | 33.08 |
| 2019-03-31 | $837k | 24k | 35.02 |
| 2018-12-31 | $379k | 11k | 33.25 |
| 2018-09-30 | $624k | 12k | 50.32 |
| 2018-06-30 | $1.0M | 18k | 59.83 |
| 2018-03-31 | $183k | 4.0k | 45.75 |
| 2017-12-31 | $183k | 4.6k | 39.78 |
| 2017-09-30 | $1.9M | 48k | 40.00 |
| 2017-06-30 | $2.5M | 57k | 43.11 |
| 2017-03-31 | $2.4M | 76k | 31.30 |
| 2016-12-31 | $568k | 23k | 25.24 |
| 2016-09-30 | $707k | 29k | 24.72 |
| 2016-06-30 | $1.0M | 49k | 20.37 |
| 2016-03-31 | $758k | 50k | 15.25 |
| 2015-12-31 | $1.0M | 75k | 13.44 |
| 2015-09-30 | $634k | 82k | 7.70 |
| 2015-06-30 | $1.1M | 65k | 16.97 |
| 2015-03-31 | $1.6M | 132k | 12.09 |
| 2014-12-31 | $890k | 107k | 8.30 |
| 2014-09-30 | $1.0M | 116k | 8.69 |
| 2014-06-30 | $1.2M | 109k | 10.95 |
| 2014-03-31 | $738k | 83k | 8.93 |
| 2013-09-30 | $6.0M | 815k | 7.33 |
| 2013-06-30 | $814k | 127k | 6.43 |
Top funds holding Supernus Pharmaceuticals
View all funds holding Supernus Pharmaceuticals